![Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days]({"type":"image" , "src" : "/sda/5944/TOC-Subject-Sample-2021-Medicine-Dentistry-Nursing-Allied-Health.jpg"})
Abstract
Reply to: Johnston JM, Schneier HA. Clarification of trial end points presented in a recent review of linaclotide. Expert Rev. Gastroenterol. Hepatol. 6(1), 13–14 (2012).
Disclaimer
This work is the opinion of the authors and does not represent the views of Expert Reviews Ltd or its employees.
Financial & competing interests disclosure
M Camilleri has consulted for Ironwood Pharmaceuticals regarding linaclotide. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.
No writing assistance was utilized in the production of this manuscript.